{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:30:01Z","timestamp":1792459801019,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T00:00:00Z","timestamp":1347753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00277-012-1569-0","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T11:31:40Z","timestamp":1347708700000},"page":"25-32","source":"Crossref","is-referenced-by-count":20,"title":["Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study"],"prefix":"10.1007","volume":"92","author":[{"given":"Esther Natalie","family":"Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cuzzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Aloe Spiriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Poloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Rigolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Alberto","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Sanpaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Rod\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,16]]},"reference":[{"key":"1569_CR1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstr\u00f6m-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937\u2013951","journal-title":"Blood"},{"key":"1569_CR2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ajh.22047","volume":"86","author":"G Garcia-Manero","year":"2011","unstructured":"Garcia-Manero G (2011) Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86:490\u2013498","journal-title":"Am J Hematol"},{"key":"1569_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02982044","volume":"75","author":"K Allampallam","year":"2002","unstructured":"Allampallam K, Shetty V, Mundle S, Dutt D, Kravitz H, Reddy PL, Alvi S, Galili N, Saberwal GS, Anthwal S, Shaikh MW, York A, Raza A (2002) Biological significance of proliferation, apoptosis, cytokines, and monocyte\/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. Int J Hematol 75:289\u2013297","journal-title":"Int J Hematol"},{"key":"1569_CR4","first-page":"591","volume":"4","author":"M Kitagawa","year":"2011","unstructured":"Kitagawa M, Kurata M, Yamamoto K, Abe S, Suzuki S, Umeda S (2011) Molecular pathology of myelodysplastic syndromes: biology of medullary stromal and hematopoietic cells. Mol Med Rep 4:591\u2013596","journal-title":"Mol Med Rep"},{"key":"1569_CR5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3109\/10428194.2011.584002","volume":"52","author":"ED Warlick","year":"2011","unstructured":"Warlick ED, Miller JS (2011) Myelodysplastic syndromes: the role of the immune system in pathogenesis. Leuk Lymphoma 52:2045\u20132049","journal-title":"Leuk Lymphoma"},{"key":"1569_CR6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2141.2007.06923.x","volume":"140","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt DL, Mhyre AJ, Marcondes M, Pogosova-Agadjanyan E, Abbasi N, Radich JP, Deeg HJ (2008) Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS? Br J Haematol 140:444\u2013453","journal-title":"Br J Haematol"},{"key":"1569_CR7","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","volume":"110","author":"D Haase","year":"2007","unstructured":"Haase D, Germing U, Schanz J, Pfeilst\u00f6cker M, N\u00f6sslinger T, Hildebrandt B, Kundgen A, L\u00fcbbert M, Kunzmann R, Giagounidis AA, Aul C, Tr\u00fcmper L, Krieger O, Stauder R, M\u00fcller TH, Wimazal F, Valent P, Fonatsch C, Steidl C (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110:4385\u20134395","journal-title":"Blood"},{"key":"1569_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/251437a0","volume":"251","author":"H Berghe Van den","year":"1974","unstructured":"Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (1974) Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 251:437\u2013438","journal-title":"Nature"},{"key":"1569_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11864-011-0165-1","volume":"12","author":"E Padron","year":"2011","unstructured":"Padron E, Komrokji R, List AF (2011) The 5q\u2212 syndrome: biology and treatment. Curr Treat Options Oncol 12:354\u2013368","journal-title":"Curr Treat Options Oncol"},{"key":"1569_CR10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","volume":"355","author":"A List","year":"2006","unstructured":"List A, Dewald G, Bennett J, Giagounidis A, Raza A, Feldman E, Powell B, Greenberg P, Thomas D, Stone R, Reeder C, Wride K, Patin J, Schmidt M, Zeldis J, Knight R (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 355:1456\u20131465","journal-title":"N Engl J Med"},{"key":"1569_CR11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.leukres.2011.05.034","volume":"35","author":"F Bras Le","year":"2011","unstructured":"Le Bras F, Sebert M, Kelaidi C, Lamy T, Dreyfus F, Delaunay J, Banos A, Blanc M, Vey N, Schmidt A, Visanica S, Eclache V, Turlure P, Beyne-Rauzy O, Guerci A, Delmer A, de Botton S, Rea D, Fenaux P, Ad\u00e8s L (2011) Treatment by lenalidomide in lower risk myelodysplastic syndrome with 5q deletion-The GFM experience. Leuk Res 35:1444\u20131448","journal-title":"Leuk Res"},{"key":"1569_CR12","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2011-01-330126","volume":"118","author":"P Fenaux","year":"2011","unstructured":"Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Ca\u00f1izo C, Guerci-Bresler A, Nilsson L, Platzbecker U, L\u00fcbbert M, Quesnel B, Cazzola M, Ganser A, Bowen D, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellstr\u00f6m-Lindberg E (2011) A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with low-\/intermediate-1-risk myelodysplastic syndromes with del5q. Blood 118:3765\u20133776","journal-title":"Blood"},{"key":"1569_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<251::AID-GCC11>3.0.CO;2-R","volume":"22","author":"RJ Jaju","year":"1998","unstructured":"Jaju RJ, Boultwood J, Oliver FJ, Kostrzewa M, Fidler C, Parker N, McPherson JD, Morris SW, M\u00fcller U, Wainscoat JS, Kearney L (1998) Molecular cytogenetic delineation of the critical deleted region in the 5q\u2212 syndrome. Genes Chromosom Cancer 22:251\u2013256","journal-title":"Genes Chromosom Cancer"},{"key":"1569_CR14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2009.53","volume":"23","author":"BL Ebert","year":"2009","unstructured":"Ebert BL (2009) Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia 23:1252\u20131256","journal-title":"Leukemia"},{"key":"1569_CR15","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.0610477104","volume":"104","author":"A Pellagatti","year":"2007","unstructured":"Pellagatti A, J\u00e4dersten M, Forsblom AM, Cattan H, Christensson B, Emanuelsson EK, Merup M, Nilsson L, Samuelsson J, Sander B, Wainscoat JS, Boultwood J, Hellstr\u00f6m-Lindberg E (2007) Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q\u2212 syndrome patients. Proc Natl Acad Sci U S A 104:11406\u201311411","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1569_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","volume":"451","author":"BL Ebert","year":"2008","unstructured":"Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR (2008) Identification of RPS14 as a 5q\u2212 syndrome gene by RNA interference screen. Nature 451:335\u2013339","journal-title":"Nature"},{"key":"1569_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2007.06833.x","volume":"139","author":"J Boultwood","year":"2007","unstructured":"Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L, Della Porta MG, J\u00e4dersten M, Killick S, Fidler C, Cazzola M, Hellstr\u00f6m-Lindberg E, Wainscoat JS (2007) Gene expression profiling of CD34+ cells in patients with the 5q\u2212 syndrome. Br J Haematol 139:578\u2013589","journal-title":"Br J Haematol"},{"key":"1569_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","volume":"16","author":"JL Barlow","year":"2010","unstructured":"Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, McKenzie AN (2010) A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q\u2212 syndrome. Nat Med 16:59\u201366","journal-title":"Nat Med"},{"key":"1569_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2141.2008.07178.x","volume":"142","author":"A Pellagatti","year":"2008","unstructured":"Pellagatti A, Hellstr\u00f6m-Lindberg E, Giagounidis A, Perry J, Malcovati L, Della Porta MG, J\u00e4dersten M, Killick S, Fidler C, Cazzola M, Wainscoat JS, Boultwood J (2008) Haploinsufficiency of RPS14 in 5q\u2212 syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol 142:57\u201364","journal-title":"Br J Haematol"},{"key":"1569_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0609.2010.01473.x","volume":"85","author":"EN Oliva","year":"2010","unstructured":"Oliva EN, Cuzzola M, Nobile F, Ronco F, D\u2019Errigo MG, Lagan\u00e0 C, Morabito F, Galimberti S, Cortelezzi A, Aloe Spiriti MA, Specchia G, Poloni A, Breccia M, Ghio R, Finelli C, Iacopino P, Alimena G, Latagliata R (2010) Changes in RPS14 expression levels during lenalidomide treatment in low- and intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion. Eur J Haematol 85:231\u2013235","journal-title":"Eur J Haematol"},{"key":"1569_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"1569_CR22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nri2252","volume":"8","author":"HF Lodish","year":"2008","unstructured":"Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8:120\u2013130","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1569_CR23","doi-asserted-by":"crossref","first-page":"e7158","DOI":"10.1371\/journal.pone.0007158","volume":"4","author":"HF Stahl","year":"2009","unstructured":"Stahl HF, Fauti T, Ullrich N, Bopp T, Kubach J, Rust W, Labhart P, Alexiadis V, Becker C, Hafner M, Weith A, Lenter MC, Jonuleit H, Schmitt E, Mennerich D (2009) miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One 4(9):e7158","journal-title":"PLoS One"},{"key":"1569_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-4-1","volume":"4","author":"H Votavova","year":"2010","unstructured":"Votavova H, Grmanova M, Dostalova Merkerova M, Belickova M, Vasikova A, Neuwirtova R, Cermak J (2010) Differential expression of microRNAs in CD34+ cells of 5q\u2212 syndrome. J Hematol Oncol 4:1","journal-title":"J Hematol Oncol"},{"key":"1569_CR25","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428190903147645","volume":"50","author":"A Pons","year":"2009","unstructured":"Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, Valera S, Rozman M, Belkaid M, Montserrat E, Monzo M (2009) Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 50:1854\u20131859","journal-title":"Leuk Lymphoma"},{"key":"1569_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","volume":"16","author":"DT Starczynowski","year":"2010","unstructured":"Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, Buckstein R, Lam W, Humphries RK, Karsan A (2010) Identification of miR-145 and miR-146a as mediators of the 5q\u2212 syndrome phenotype. Nat Med 16:49\u201358","journal-title":"Nat Med"},{"issue":"1","key":"1569_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jmcb\/mjq040","volume":"3","author":"Z Feng","year":"2011","unstructured":"Feng Z, Zhang C, Wu R, Hu W (2011) Tumor suppressor p53 meets microRNAs. J Mol Cell Biol 3(1):44\u201350","journal-title":"J Mol Cell Biol"},{"key":"1569_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4161\/cc.9.5.11156","volume":"95","author":"D Starczynowski","year":"2010","unstructured":"Starczynowski D, Karsan A (2010) Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q. Cell Cycle 95:855\u2013856","journal-title":"Cell Cycle"},{"key":"1569_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hoc.2010.02.008","volume":"24","author":"DT Starczynowski","year":"2010","unstructured":"Starczynowski DT, Karsan A (2010) Innate immune signaling in the myelodysplastic syndromes. Hematol Oncol Clin North Am 24:343\u2013359","journal-title":"Hematol Oncol Clin North Am"},{"key":"1569_CR30","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2010-12-324715","volume":"118","author":"MS Kumar","year":"2011","unstructured":"Kumar MS, Narla A, Nonami A, Mullally A, Dimitrova N, Ball B, McAuley JR, Poveromo L, Kutok JL, Galili N, Raza A, Attar E, Gilliland DG, Jacks T, Ebert BL (2011) Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q\u2212 syndrome. Blood 118:4666\u20134673","journal-title":"Blood"},{"key":"1569_CR31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","volume":"108","author":"BD Cheson","year":"2006","unstructured":"Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108:419\u2013425","journal-title":"Blood"},{"key":"1569_CR32","volume-title":"The ACT cytogenetics laboratory manual","author":"KM Gustashaw","year":"1991","unstructured":"Gustashaw KM (1991) Chromosome stains. In: Barch MJ (ed) The ACT cytogenetics laboratory manual, 2nd edn. The Association of Cytogenetic Technologists, Raven, New York","edition":"2"},{"key":"1569_CR33","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"LG Shaffer","year":"2005","unstructured":"Shaffer LG, Tommerup N (2005) An International System for Human Cytogenetic Nomenclature. Karger, Basel"},{"key":"1569_CR34","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2009-10-245001","volume":"115","author":"EA Hod","year":"2010","unstructured":"Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, Francis KP, Della-Latta P, Whittier S, Sheth S, Hendrickson JE, Zimring JC, Brittenham GM, Spitalnik SL (2010) Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 115:4284\u20134292","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1569-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1569-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1569-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:27Z","timestamp":1559037027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1569-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1569-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,16]]}}}